| 000 | 01873 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516044350.0 | ||
| 264 | 0 | _c20120419 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1365-2796 | ||
| 024 | 7 |
_a10.1111/j.1365-2796.2011.02422.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeters, S A E | |
| 245 | 0 | 0 |
_aManual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison. _h[electronic resource] |
| 260 |
_bJournal of internal medicine _cMar 2012 |
||
| 300 |
_a247-56 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAtherosclerosis _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCarotid Arteries _xdrug effects |
| 650 | 0 | 4 |
_aCarotid Intima-Media Thickness _xinstrumentation |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorobenzenes _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aRosuvastatin Calcium |
| 650 | 0 | 4 |
_aSulfonamides _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTunica Intima _xdrug effects |
| 650 | 0 | 4 |
_aTunica Media _xdrug effects |
| 700 | 1 | _aden Ruijter, H M | |
| 700 | 1 | _aPalmer, M K | |
| 700 | 1 | _aGrobbee, D E | |
| 700 | 1 | _aCrouse, J R | |
| 700 | 1 | _aO'Leary, D H | |
| 700 | 1 | _aEvans, G W | |
| 700 | 1 | _aRaichlen, J S | |
| 700 | 1 | _aLind, L | |
| 700 | 1 | _aBots, M L | |
| 773 | 0 |
_tJournal of internal medicine _gvol. 271 _gno. 3 _gp. 247-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2796.2011.02422.x _zAvailable from publisher's website |
| 999 |
_c20978999 _d20978999 |
||